1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Denmark >
  5. Norgine Acquires Azanta A/S

M&A Deal Summary

Norgine Acquires Azanta A/S

On March 24, 2020, Norgine acquired life science company Azanta A/S from EEP Advisers

Acquisition Highlights
  • This is Norgine’s 4th transaction in the Life Science sector.
  • This is Norgine’s 1st transaction in Denmark.

M&A Deal Summary
Date 2020-03-24
Target Azanta A/S
Sector Life Science
Buyer(s) Norgine
Sellers(s) EEP Advisers
Deal Type Add-on Acquisition

Target

Azanta A/S

Valby, Denmark
Azanta A/S is a privately-owned specialty pharma company primarily operating within oncology, women's health and addiction medicine. Azanta A/S currently markets (or makes available under special authorization) a portfolio of specialty pharmaceutical products, including Nimorazole a hypoxic radiosensitizer for the treatment of head and neck cancer patients undergoing primary radiotherapy and Angusta® for labor induction.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Norgine

Amsterdam, Netherlands
Category Company
Founded 1906
Sector Life Science
DESCRIPTION

Norgine is an independent specialty pharmaceutical company. Norgine’s focus is the development and marketing of pharmaceutical products that address significant unmet clinical needs in therapeutic areas such as gastroenterology, hepatology, and critical and supportive care. Norgine was formed in 1906 and is based in Amsterdam, Netherlands.

DEAL STATS #
Overall 5 of 6
Sector: Life Science M&A 4 of 5
Type: Add-on Acquisition M&A Deals 2 of 3
Country: Denmark M&A 1 of 1
Year: 2020 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-05-11 Merus Labs International

Toronto, Ontario, Canada

Merus Labs International, Inc. is a specialty pharmaceutical company focused on acquiring and optimizing legacy and growth products. The Company leverages its expertise and scalable platform across Europe, Canada and select other markets to deliver value.

Buy $342M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-08-07 Endocuff

Leeds, United Kingdom

ARC Medical Design Ltd. is a provider of medical products. ARC Medical Design was founded in 2008 and is based in Leeds, United Kingdom.

Sell -

Seller(S) 1

SELLER

EEP Advisers

Investor Investor

Category Venture Capital Firm
Founded 1999
Size Small
Type Sector Focused
DESCRIPTION

EEP is a Venture Capital investment firm that provides both dedication and passion on top of the financial investment itself. With more than 25 years of investment experience in life sciences, EEP provides deep sectorial knowledge and an established network. EEP was founded in 1999 and is based in London, England.

DEAL STATS #
Overall 5 of 5
Sector: Life Science M&A 4 of 4
Type: Add-on Acquisition M&A Deals 4 of 4
Country: Denmark M&A 2 of 2
Year: 2020 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-01-02 Bactolife

Copenhagen, Denmark

Bactolife develops novel biological solutions to reduce the risk of gastrointestinal infections in humans and animals. Antimicrobial resistance development is a major and increasing threat to human health worldwide. Bactolife was founded in 2017 and is based in Copenhagen, Denmark.

Buy -
Mergr

Solution for

Product

Company

Legal